Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:administeredBy |
oral tablet
oral capsule |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:contains_active_ingredient |
gptkb:morphine_sulfate
|
| gptkbp:contraindication |
respiratory depression
paralytic ileus acute or severe bronchial asthma |
| gptkbp:controlled_substance_schedule |
gptkb:Schedule_II_(US)
|
| gptkbp:form |
immediate release
|
| https://www.w3.org/2000/01/rdf-schema#label |
MSIR
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
various generic manufacturers
|
| gptkbp:notRecommendedFor |
mild pain
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
addiction
overdose |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation drowsiness respiratory depression |
| gptkbp:standsFor |
gptkb:Morphine_Sulfate_Immediate_Release
|
| gptkbp:used_in |
chronic pain
acute pain |
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:Purdue_Pharma
|
| gptkbp:bfsLayer |
6
|